Extra intravenous Ustekinumab reinduction is an effective optimization strategy for patients with refractory Crohn’s disease

OBJECTIVES: Ustekinumab (UST) optimization strategies, including shortening intervals and intravenous reinduction, should be administered to patients with partial or loss of respond. Evidence comparing these types of optimization treatments is limited. We evaluated the efficacy and safety of weight-...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Jiayin, Peng, Xiang, Zhong, Yingkui, Su, Tao, Bihi, Adam, Zhao, Junzhang, Liu, Tao, Wang, Wei, Hu, Pinjin, Zhang, Min, Zhi, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406215/
https://www.ncbi.nlm.nih.gov/pubmed/37554510
http://dx.doi.org/10.3389/fmed.2023.1105981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406215/
https://www.ncbi.nlm.nih.gov/pubmed/37554510
http://dx.doi.org/10.3389/fmed.2023.1105981

Ejemplares similares